Cargando…
Chloroquine and hydroxychloroquine as a repurposed agent against COVID-19: a narrative review
The predicament arising from the coronavirus disease 2019 (COVID-19) pandemic has become one of the most significant modern public health challenges. Despite uncertainties in the viral determinants and pathogenesis, it is crucial to accurately inspect all available evidence to construct accurate cli...
Autores principales: | Acharya, Yogesh, Sayed, Abida |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7404096/ https://www.ncbi.nlm.nih.gov/pubmed/32821381 http://dx.doi.org/10.1177/2049936120947517 |
Ejemplares similares
-
Clinical evidence for repurposing chloroquine and hydroxychloroquine as antiviral agents: a systematic review
por: Rodrigo, C., et al.
Publicado: (2020) -
Repurposing Drugs for COVID-19: Pharmacokinetics and Pharmacogenomics of Chloroquine and Hydroxychloroquine
por: Babayeva, Mariana, et al.
Publicado: (2020) -
Chloroquine and hydroxychloroquine in the treatment of malaria and repurposing in treating COVID-19
por: Lei, Zi-Ning, et al.
Publicado: (2020) -
Convalescent Blood Products in COVID-19: A Narrative
Review
por: Chua Vi Long, Keegan, et al.
Publicado: (2020) -
Repurposing Drugs in Oncology (ReDO)—chloroquine and hydroxychloroquine as anti-cancer agents
por: Verbaanderd, Ciska, et al.
Publicado: (2017)